Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Insulin Pumps pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Diabetes Care Devices, Forecast to 2028
... is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions. The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, ... Read More
-
Diabetic Foot Ulcers - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Diabetic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Global Endocrinology Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 140400 million by 2030 with a CAGR of 5.0% during review period. Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and ... Read More
-
HbA1c Testing Market, By Type (Laboratory-based Testing, Point-of-Care Testing), Technology (Immunoassays, Chromatography, Boronate Affinity Chromatography, HPLC), End-use (Hospital, Diagnostic Labs, Homecare) –Forecast (2024 – 2032)
... during 2024-2032, driven by the rising prevalence of diabetes. According to Internation Diabetes Federation, in 2021, 537 million adults, or approximately 1 in 10, were living with diabetes. This number is projected to increase significantly, ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029
... market is projected to reach USD 238.3 billion by 2029 from USD 163.5 billion in 2024, at a CAGR of 7.8% during the forecast period of 2024 to 2029. The growth of this market can ... Read More
-
Global Hyper Personalized Medicine Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Product (Medicine Diagnostics, Medicine Therapeutics, Medical Care, Nutrition and Wellness and Other Product Types), Application, End-User, Region, By Country: 2020-2030
... A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Hyper Personalized Medicine Market (2024 Edition)”. According to the report, Global Hyper Personalized Medicine Market registered market value of around ... Read More
-
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis
... forecast model for the Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity market through 2033. The use of GLP-1R agonists is expected to quadruple in the next 10 years, at a ... Read More
-
Personalized Medicine Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Early Detection/Screening, Indication, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By Region and Competition, 2019-2029F
... 2019-2029F Global Personalized Medicine Biomarkers Market was valued at USD 14.11 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In recent years, ... Read More
-
India HbA1c Market Research Report Forecast to 2032
... blood sugar over the past two to three months. It is also known as glycated haemoglobin or A1C. This test is important for people with diabetes because it provides a more comprehensive view of blood ... Read More
-
Ultrasonic Air Bubble Detectors Market Forecasts to 2030 – Global Analysis By Product (Portable, Fixed, Batch, Inline, Stand-alone and Other Products), Channel Type, Output Signal, Technology, Application, End User and By Geography
... MRC, the Global Ultrasonic Air Bubble Detectors Market is accounted for $115.17 million in 2023 and is expected to reach $232.61 million by 2030 growing at a CAGR of 10.2% during the forecast period. Ultrasonic ... Read More
-
2024 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with Updated Recession Risk Impact
... Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with ... Read More
-
Diabetes Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 79.25 billion in 2023, and the market is now projected to grow from USD 89.39 billion in 2024 to USD 153.98 billion by 2032, exhibiting a CAGR of 7.0% during the forecast period of 2024-2032. ... Read More
-
Global Diabetes Drug Market Report by Drug class (Insulin, GLP-1 Receptor Agonists, DPP-4 Inhibitors, SGLT2 Inhibitors, and Others), Diabetes types (Type 1 Diabetes, Type 2 Diabetes), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channels (Hospital Pharmacies, Rental Pharmacies, Online Pharmacies, and Others), Region and Company Analysis 2024-2032
... Pharmacies, Rental Pharmacies, Online Pharmacies, and Others), Region and Company Analysis 2024-2032 Global Diabetes Drug Market size is anticipated to be almost US$ 107.02 Billion by 2032. The CAGR for the global diabetes drug market ... Read More
-
Prefilled Syringe Market: Trends, Opportunities and Competitive Analysis
... offer numerous advantages over traditional vials and syringes, including accurate dosing, reduced risk of contamination, ease of administration, and improved patient adherence. This report provides a comprehensive analysis of the prefilled syringe market, including market ... Read More
-
EPA and DHA Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... USD 2.76 billion by 2029, growing at a CAGR of 7.51% during the forecast period (2024-2029). The market for EPA and DHA is primarily driven by increasing awareness regarding potential health benefits associated with fatty ... Read More
-
Insulin Pump Market Report by Types (Tethered Pumps, Patch Pumps, Consumables), Diseases (Type 1 Diabetes, Type 2 Diabetes), Accessories (Action Figures Insulin Reservoirs, Infusion Sets, Infusion Set Insertion Devices), End-user (Action Figures Hospital and Clinics, Home Care, Others) Countries and Company Analysis 2024-2032
... Home Care, Others) Countries and Company Analysis 2024-2032 Global Insulin Pump Market size is expected to be about US$ 11.12 Billion by 2032. The CAGR for the global insulin pump market from 2024 to 2032 ... Read More
-
2024 Global Forecast for Diabetes Care Devices Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Pet Diabetes Care Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Continuous Glucose Monitoring System Market Research Report Forecast till 2032
... as a conspicuous driver energizing the development of the worldwide continuous glucose monitoring systems market. Diabetes has arrived at plague extents, with a stunning ascent in the quantity of impacted people universally. As per the ... Read More
-
Global Diabetes Devices Databank Market Report
... 2031. Insulin Delivery Devices segment is expected to be the highest contributor to this market, with $17,489.8 Million in 2022, and is anticipated to reach $27,348.1 Million by 2031, registering a CAGR of 5.14%. Blood ... Read More
-
Global Artificial Pancreas Device System Databank Market Report
... intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding ... Read More
-
Global Digital Diabetes Management Databank Market Report
... 2023 to 2031. Continuous Blood Glucose Monitoring System segment is expected to be the highest contributor to this market, with $4,876.9 Million in 2022, and is anticipated to reach $9,140.7 Million by 2031, registering a ... Read More
-
Global Artificial Pancreas Device System Databank Market Report.pdf
... 5.40% from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of ... Read More
-
Digital Marketing Trends in Type 2 Diabetes - April 2024
... 2023 to March 2024. This was followed by Rybelsus.com with over 9,000,000 visits. Overall, the highest proportion of traffic to top branded patient T2D websites originated from direct sources, followed by organic sources. Farxiga.com had ... Read More
Research Assistance
